{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:11:45Z","timestamp":1790244705024,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hibbard Williams Endowed Chair"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["TR000002"],"award-info":[{"award-number":["TR000002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.thromres.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T16:33:14Z","timestamp":1489681994000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-9457","authenticated-orcid":false,"given":"Ann","family":"Brunson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-1121","authenticated-orcid":false,"given":"Richard","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Wun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.thromres.2017.03.012_bb0005","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archinte.164.14.1541","article-title":"Twenty-one-year trends in the use of inferior vena cava filters","volume":"164","author":"Stein","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.03.012_bb0010","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.thromres.2017.03.012_bb0015","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2017.03.012_bb0020","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2017.03.012_bb0025","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.thromres.2017.03.012_bb0030","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.thromres.2012.10.007","article-title":"Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry","volume":"131","author":"Gussoni","year":"2013","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2017.03.012_bb0035","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","article-title":"Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry","volume":"4","author":"Monreal","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2017.03.012_bb0040","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2017.03.012_bb0045","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1076029608315165","article-title":"Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome","volume":"15","author":"Barginear","year":"2009","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.thromres.2017.03.012_bb0050","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/cncr.20578","article-title":"Use of inferior vena caval filters and survival in patients with malignancy","volume":"101","author":"Wallace","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2017.03.012_bb0055","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2352","article-title":"High variation between hospitals in vena cava filter use for venous thromboembolism","author":"White","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.03.012_bb0060","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.thromres.2015.02.002","article-title":"Vena cava filter use in cancer patients with acute venous thromboembolism in California","volume":"135","author":"Ho","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.03.012_bb0065","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020338","article-title":"Outcomes after vena cava filter use in non-cancer patients with acute venous thromboembolism: a population-based study","author":"White","year":"2016","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2017.03.012_bb0070","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/S0049-3848(16)30112-8","article-title":"Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes","volume":"140","author":"Brunson","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.03.012_bb0075","series-title":"Proceedings\/Amia Symposium","first-page":"305","article-title":"Analysis of identifier performance using a deterministic linkage algorithm","author":"Grannis","year":"2002"},{"issue":"31","key":"10.1016\/j.thromres.2017.03.012_bb0080","article-title":"Cross-system data linkage for treatment outcome evaluation: lessons learned from the California treatment outcome project","volume":"2","author":"Hser","year":"2008","journal-title":"Eval. Program Plann."},{"issue":"1","key":"10.1016\/j.thromres.2017.03.012_bb0085","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.thromres.2010.03.009","article-title":"Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States","volume":"126","author":"White","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2017.03.012_bb0095","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1148\/radiology.216.1.r00jl1254","article-title":"Inferior vena caval filters: review of a 26-year single-center clinical experience1","volume":"216","author":"Athanasoulis","year":"2000","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.thromres.2017.03.012_bb0100","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.amjmed.2011.02.021","article-title":"Increasing use of vena cava filters for prevention of pulmonary embolism","volume":"124","author":"Stein","year":"2011","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2017.03.012_bb0105","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (anticoagulation and risk factors in atrial fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2017.03.012_bb0110","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2017.03.012_bb0115","author":"Elixhauser"},{"issue":"4","key":"10.1016\/j.thromres.2017.03.012_bb0120","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1077558707301963","article-title":"Understanding and enhancing the value of hospital discharge data","volume":"64","author":"Schoenman","year":"2007","journal-title":"Med. Care Res. Rev."},{"issue":"6, Supplement","key":"10.1016\/j.thromres.2017.03.012_bb0125","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arth.2009.03.008","article-title":"All-patient refined diagnosis-related groups in primary arthroplasty","volume":"24","author":"Lavernia","year":"2009","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.thromres.2017.03.012_bb0130","article-title":"The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: a simulation study","author":"Austin","year":"2014","journal-title":"Stat. Methods Med. Res."},{"issue":"4","key":"10.1016\/j.thromres.2017.03.012_bb0135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ki.2011.388","article-title":"Issues regarding \u2018immortal time\u2019 in the analysis of the treatment effects in observational studies","volume":"81","author":"Liu","year":"2012","journal-title":"Kidney Int."},{"issue":"23","key":"10.1016\/j.thromres.2017.03.012_bb0140","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of Guarantee-Time Bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2017.03.012_bb0145","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"Br. Med. J."},{"issue":"446","key":"10.1016\/j.thromres.2017.03.012_bb0150","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"4","key":"10.1016\/j.thromres.2017.03.012_bb0155","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/1538574406291821","article-title":"Inferior vena cava filter placement in late-stage cancer","volume":"40","author":"Schunn","year":"2006","journal-title":"Vasc. Endovasc. Surg."},{"issue":"12","key":"10.1016\/j.thromres.2017.03.012_bb0160","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1001\/archinte.1987.00370120113020","article-title":"Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter?","volume":"147","author":"Olin","year":"1987","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.03.012_bb0165","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0741-5214(98)70054-0","article-title":"Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?","volume":"28","author":"Ihnat","year":"1998","journal-title":"J. Vasc. Surg."},{"issue":"3","key":"10.1016\/j.thromres.2017.03.012_bb0170","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","author":"P.S. Group","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.thromres.2017.03.012_bb0175","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"9","key":"10.1016\/j.thromres.2017.03.012_bb0180","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.amjmed.2013.03.030","article-title":"Case fatality rate with vena cava filters in hospitalized stable patients with cancer and pulmonary embolism","volume":"126","author":"Stein","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2017.03.012_bb0185","author":"U.F.a.D. Administration"},{"issue":"7","key":"10.1016\/j.thromres.2017.03.012_bb0190","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jacr.2010.12.021","article-title":"Placement and removal of inferior vena cava filters: national trends in the medicare population","volume":"8","author":"Duszak","year":"2011","journal-title":"J. Am. Coll. Radiol."},{"issue":"2","key":"10.1016\/j.thromres.2017.03.012_bb0195","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2017.03.012_bb0200","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.thromres.2017.03.012_bb0205","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jth.12923","article-title":"Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN study","volume":"13","author":"Francis","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2017.03.012_bb0210","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817302360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817302360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T09:21:16Z","timestamp":1535966476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817302360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":41,"alternative-id":["S0049384817302360"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.03.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}